Nobel Award Recognizes Groundbreaking Body's Defenses Discoveries

The prestigious award in Physiology or Medicine was granted for revolutionary discoveries that illuminate how the immune system attacks harmful infections while protecting the body's own cells.

A trio of renowned researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this accolade.

Their work identified unique "sentinels" within the defense system that eliminate malfunctioning immune cells that could attacking the body.

These findings are now enabling innovative therapies for autoimmune diseases and cancer.

These laureates will share a prize fund worth 11 million SEK.

Decisive Findings

"The research has been decisive for understanding how the body's defenses functions and why we don't all develop severe self-attack conditions," stated the chair of the Nobel Committee.

The team's research explain a fundamental mystery: How does the immune system protect us from countless invaders while keeping our own tissues intact?

The immune system employs white blood cells that search for signs of infection, including viruses and bacteria it has not met before.

These defenders utilize detectors—known as recognition units—that are generated randomly in countless combinations.

This gives the defense network the capacity to fight a wide array of threats, but the unpredictability of the process unavoidably creates white blood cells that can target the host.

Protectors of the Immune System

Researchers previously knew that some of these problematic white blood cells were eliminated in the thymus—the site where immune cells mature.

This year's award honors the discovery of T-reg cells—described as the body's "peacekeepers"—which patrol the system to neutralize any immune cells that attack the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.

The prize committee stated, "The findings have established a novel area of research and accelerated the development of new treatments, for example for cancer and immune disorders."

In cancer, regulatory T-cells prevent the system from fighting the growth, so studies are focused on lowering their numbers.

In autoimmune diseases, experiments are testing increasing regulatory T-cells so the body is no longer under attack. A comparable method could also be useful in reducing the risks of organ transplant rejection.

Pioneering Experiments

Professor Shimon Sakaguchi, from a Japanese institution, performed experiments on mice that had their immune gland removed, causing self-attack conditions.

He showed that injecting defense cells from other mice could stop the illness—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in rodents and people that led to the discovery of a genetic factor vital for the way T-regs operate.

"The groundbreaking work has revealed how the immune system is kept in check by T-reg cells, stopping it from accidentally targeting the body's own tissues," commented a leading physiology specialist.

"The research is a striking illustration of how basic biological research can have broad implications for human health."